PL EN


Preferences help
enabled [disable] Abstract
Number of results
2015 | 1 | 1 |
Article title

Angiogenic Effect of Bioactive Borate Glass
Microfibers and Beads in the Hairless Mouse

Content
Title variants
Languages of publication
EN
Abstracts
EN
The purpose of this project was to investigate
the angiogenic mechanism of bioactive borate glass for
soft tissue repair in a ‘hairless’ SKH1 mouse model. Subcutaneous
microvascular responses to bioactive glass microfibers
(45S5, 13-93B3, and 13-93B3Cu) and bioactive
glass beads (13-93, 13-93B3, and 13-93B3Cu) were assessed
via: noninvasive imaging of skin microvasculature; histomorphometry
of microvascular densities; and quantitative
PCR measurements of mRNA expression of VEGF
and FGF-2 cytokines. Live imaging via dorsal skin windows
showed the formation at twoweeks of a halo-like structure
infused with microvessels surrounding implanted boratebased
13-93B3 and 13-93B3Cu glass beads, a response not
observed with silicate-based 13-93 glass beads. Quantitative
histomorphometry of tissues implanted with plugs of
45S5, 13-93B3, and 13-93B3Cu glass microfibers revealed
microvascular densities that were 1.6-, 2.3-, and 2.7-times
higher, respectively, than the sham control valueswhereas
13-93, 13-93B3, and 13-93B3Cu glass beads caused the microvascular
density to increase 1.3-, 1.6-, and 2.5-fold,
respectively, relative to sham controls. Quantitative PCR
measurements indicate a marginally significant increased
expression of VEGF mRNA in tissues with 13-93B3Cu glass
beads, an outcome that supported the hypothesis that
copper-doped borate glass could promote VEGF expression
followed by angiogenesis for enhanced wound healing.
Publisher
Year
Volume
1
Issue
1
Physical description
Dates
received
15 - 10 - 2015
online
24 - 12 - 2015
accepted
5 - 12 - 2015
References
  • [1] Brown R., Watters R., Day D., Angiogenic Response of BioactiveBorate Glass Beads & Microfibers in “Hairless” Mice, TheAmerican Ceramic Society-Glass & Optical Materials Divisionand Deutsche Glastechnische Gesellschaft Joint Annual Meeting,Miami, FL, 17–21 May 2015.
  • [2] Chandan S., Gordillo M., Sashwati R., Kirsner R., Lambert L.,Hunt T.K., et al., Human skin wounds: a major and snowballingthreat to public health and the economy, Wound Repair Regen2009, 17, 763–771.[WoS][Crossref]
  • [3] Wu S., Driver V., Wrobel J., Armstrong D., Foot ulcers in thediabetic patient, prevention and treatment, Vasc Health RiskManag 2007, 3, 65–76.
  • [4] Caputo G., Cavanagh P., Ulbrecht J., Gibbons G., Karchmer A.,Assessment and management of foot disease in patients withdiabetes, New Engl J Med 1994, 13, 854-860.[Crossref]
  • [5] Keshaw H., Forbes A., Day R., Release of angiogenic growthfactor from cells encapsulated in alginate beads with bioactiveglass, Biomaterials 2005, 26, 4171–4179.[Crossref]
  • [6] Barralet J., Gbureck U., Habibovic P., Vorndran E., Gerard C.,Doillon C., Angiogenesis in calcium phosphate scaffolds by inorganiccopper ion release, Tissue Eng 2009, 15, 1601–1608.[Crossref]
  • [7] Li J., Zhang Y., Kirsner R., Angiogenesis in wound repair: Angiogenicgrowth factors and the extracellular matrix, Microsc ResTech 2003, 60, 107–114.[Crossref]
  • [8] Cole R., Liu F., Herron B., Imaging of angiogenesis: past, presentand future, In: A. Mendez – Vilas, J. Diaz (Eds.), Microscopy: Science,Technology, Applications and Education, Vol 3, Badajoz,Spain, 2010.
  • [9] Folkman J., Shing Y., Angiogenesis, J Biol Chem 1992, 267,10931–10934.
  • [10] Shih S., Robinson G., Perruzzi C., Calvo A., Desai K., Green J.,et al., Molecular profiling of angiogenesis markers, Am J Pathol2002, 161, 35–40.
  • [11] ClaytonW., Elasy T., A review of the pathophysiology, classification,and treatment of foot ulcers in diabetic patients, Clin Diabetes2009, 27, 52–58.[Crossref]
  • [12] Mohammad G., Pandey H., Tripathi K., Diabetic wound healingand its angiogenesis with special reference to nanoparticles,Dig J Nanomater Bios 2008, 3, 203–208.
  • [13] Falanga V., Wound healing and its impairment in the diabeticfoot, Lancet 2005, 366, 1736–43.
  • [14] Demidova-Rice T., Durham J., Herman I., Wound healing angiogenesis:innovations and challenges in acute and chronicwound healing, Adv Wound Care 2012, 1, 17–22.
  • [15] Papanas N., Efstratios M., Becaplermin gel in the treatment ofdiabetic neuropathic foot ulcers, Clin Interv Aging, Jun 2008,3(2), 233–240.
  • [16] Giavazzi R., Sennino B., Coltrini D., Garofalo A., Dossi R., RoncaR., et al., Distinct role of fibroblast growth factor-2 and vascular endothelial growth factor on tumor growth and angiogenesis,Am J Pathol, Jun 2003, 162, 1913–1926.[Crossref]
  • [17] Witkowski J., Parish L., Rational approach to wound care, Int JDermatol 1992, 31, 27–28.[Crossref]
  • [18] Fang R., Galiano R., A review of becaplermin gel in the treatmentof diabetic neuropathic foot ulcers, Biologics, 2008, 2, 1–12.
  • [19] Hoppe A., Mouriñob V., Boccaccini A., Therapeutic inorganicions in bioactive glasses to enhance bone formation and beyond,Biomater Sci 2013, 1, 254–256.[WoS][Crossref]
  • [20] Chen Q., Zhu C., Thouas G., Progress and challenges in biomaterialsused for bone tissue engineering: bioactive glasses andelastomeric composites, Prog Biomater 2012, 1(1), 2.[Crossref]
  • [21] Haro Durand L.A., Gongora A., Porto-Lopez J.M., Boccaccini A.R.,Zago M.P., Baldi A., et al., In vitro endothelial cell response toionic dissolution products from a boron-doped bioactive glassin the SiO2–CaO–P2O5–Na2O system, J Mater Chem B 2014, 2,7620–7630.[WoS][Crossref]
  • [22] Haro Durand L.A., Vargas G.E., Romero N.M., Vera-Mesones R.,Porto-Lopez J.M., Boccaccini A.R., et al., Angiogenic effects ofionic dissolution products released from a boron-doped 45S5bioactive glass, J Mater Chem B 2015, 3, 1142–1148.[Crossref][WoS]
  • [23] Jung S., Borate Based Bioactive Glass Scaffolds for Hard andSoft Tissue Engineering, Ph.D Dissertation, Missouri Universityof Science and Technology, Rolla, MO, 2010.
  • [24] Taylor P., personal communication, Phelps County RegionalMedical Center, Rolla, MO. 2012.
  • [25] Lin Y., Brown R., Jung S., Day D., Angiogenic effects of borateglass microfibers in a rodent model, J Biomed Mat Res A 2014,102(12), 4491–4499.
  • [26] Eliza M., Ben I., Reuven B., Histopathological periodic acid–schiff stains of nail clippings as a second-line diagnostic toolin onychomycosis, Am J Dermatopath 2012, 34, 270–273.[Crossref][WoS]
  • [27] Chomczynski P., Sacchi N., Single-step method of RNA isolationby acid guanidiniumthiocyanate-phenol-chloroform extraction,Anal Biochem 1987, 162, 156–9.[Crossref]
  • [28] Chomczynski P., Sacchi N., The single-step method of RNA isolationby acid guanidinium thiocyanate-phenol-chloroform extraction:twenty-something years on, Nat Protoc 2006, 1, 581–585.[Crossref]
  • [29] Wong M., Medrano J., Real-time PCR for mRNA quantitation,BioTechniques 2005, 39, 75–85.[Crossref]
  • [30] Livak K., Schmittgen T., Analysis of relative gene expressiondata using real-time quantitative PCR and the 2-
  • [Delta]
  • [Delta]Ctmethod, Methods 2001, 25, 402–408.
  • [31] Liu D., Handbook of Nucleic Acid Purification, CLC press, BocaRaton, FL. 2009.
  • [32] Zhao S., Li L., Wang H., Zhang Y., Cheng X., Zhou N., et al.,Wound dressings composed of copper-doped borate bioactiveglass microfibers stimulate angiogenesis and heal fullthicknessskin defects in a rodent model, Biomaterials 2015, 53,379–391.[WoS][Crossref]
  • [33] Kucan J., Robson M., Heggers J., Ko F., Comparison of silver sulfadiazine,povidone-iodine and physiologic saline in the treatmentof chronic pressure ulcers, J Am Geriatr Soc 1981, 29, 232–235.[Crossref]
  • [34] Harris E., A requirement for copper in angiogenesis, Nutr Rev2004, 62, 60–64.[Crossref]
  • [35] Hu G., Copper stimulates proliferation of human endothelialcells under culture, J Cellular Biochem 1998, 69, 326–335.[Crossref]
  • [36] Sen C.K., Copper-induced vascular endothelial growth factor expressionand wound healing, Am J Physiol 2002, 282, H1821–H1827.
  • [37] Emanueli C., Madeddu P., Angiogenesis gene therapy to rescueischemic tissues: achievements and future directions, BritJ Pharmacol 2001, 133, 951–958.
Document Type
Publication order reference
YADDA identifier
bwmeta1.element.-psjd-doi-10_1515_bglass-2015-0017
Identifiers
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.